HYPOTHYROIDISM REDUCES MAMMARY TUMOR PROGRESSION VIA Β-CATENIN-ACTIVATED INTRINSIC APOPTOTIC PATHWAY IN RATS

FANELLI MA; SASSO CV; LÓPEZ FONTANA C; PISTONE CREYDT V; SANTIANO F; CARÓN RW; CUELLO CARRIÓN FD; ZYLA L

HISTOCHEMISTRY AND CELL BIOLOGY.

SPRINGER

Lugar: Berlin; Año: 2017 p. 759 - 769

0948-6143

Experimental hypothyroidism retards mammary carcinogenesis promoting apoptosis of tumor cells. β-catenin plays a critical role in cell adhesion and intracellular signaling pathways conditioning the prognosis of breast cancer. However, the mechanistic connections associated with the expression of β-catenin in thyroid status and breast cancer are not known. Therefore, we studied the relationship between the expression and localization of β-catenin and apoptosis in mammary tumors induced by 7,12-dimethylbenz(a)anthracene (DMBA) in hypothyroid (Hypot) and euthyroid (EUT) rats. Female Sprague‑Dawley rats were treated with a dose of DMBA (15 mg/rat) at 55 days of age and were then divided into two groups: HypoT (0.01% 6-N-propyl-2-thiouracil in drinking water, n=54) and EUT (untreated control, n= 43). Latency, incidence and progression of tumors were determined. At sacrifice, tumors were obtained for immunohistological studies and Western Blot. The latency was longer (p